
Private practice, academics, industry-- I did it all. Views are my own. I tweet what I find interesting, board worthy, and fun. #iLOVErheumatology.
Joined November 2011
- Tweets5.4K
- Following324
- Followers4.8K
- Likes7.6K
Serous retinopathy is a complication of lupus nephritis and may mimic HCQ retinopathy. - Dr M Petri on ophthalmology may be too quick to blame eye diseases on HCQ. #CCRW26
1 point increase in the SLICC damage index increases mortality by 34% - Petri #CCRW26
aPLs and HTN drive most of the strokes in SLE morbidity/mortality. - Petri #CCRW26
Petri recc that we pay attention to the 3 things that increases organ same and SLE death: 1. Disease activity 2. Steroids 3. Comordities #CCRW26
Protocol kidney biopsy at 1 year may be helpful to see if pts are in remission. As pts in complete renal response (CRR) may have active LN - M Petri #CCRW26
Non LN on renal biopsies will show CKD. Modify risks with RAASi, SGLT2i/GLP1i - M Petri #CCRW26
From AMP study, 71% SLE pts with microalbuminuria had LN, almost half of these have “actionable” LN… meaning you should treat. - M Petri #CCRW26
“Microalbuminuria is bad.” It increases mortality, esp for men and increases MACE. Lupus nephritis doubles the risk of mortality. - M Petri #CCRW26
If a patient’s HCQ level is persistently low despite adherence verification, see if it is taking the med with a binder (eg magnesium, antacids)- have them take HCQ separate from other med/supplements - M Petri Pearls #CCRW26
TheDaoIndex retweeted
✅ DO YOU COLLABORATE with OTHERS for your #LUPUS #RESEARCH?
-We analyzed 22813 publications from 76 536 authors, from 142 countries 🌏🌎🌍 to perform a network analysis of relationships between international lupus authors
👉 Openaccess link: doi.org/10.1136/lupus-2026-0…
Petri Pearls Part 3
1. “Lupus nephritis is like voting in Chicago” Treat it early and often.
2. 3rd leading cause of deaths is Infection. Pls #vaccinate. Vaccines do not cause SLE or Lupus flares.
#CCRW26 @RheumNow
Petri’s Pearls Part 2
1. HCQ and hyperpigmentation is usually in those who are anticoagulants or antimatter agents.
12. ACEi/ARBs are protective against venous thrombosis (low dose ASA does not reduce risk for thrombosis)













